rs61747868

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_012293.3(PXDN):​c.4088G>A​(p.Gly1363Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00165 in 1,613,980 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0073 ( 14 hom., cov: 33)
Exomes 𝑓: 0.0011 ( 15 hom. )

Consequence

PXDN
NM_012293.3 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.148

Publications

5 publications found
Variant links:
Genes affected
PXDN (HGNC:14966): (peroxidasin) This gene encodes a heme-containing peroxidase that is secreted into the extracellular matrix. It is involved in extracellular matrix formation, and may function in the physiological and pathological fibrogenic response in fibrotic kidney. Mutations in this gene cause corneal opacification and other ocular anomalies, and also microphthalmia and anterior segment dysgenesis. [provided by RefSeq, Aug 2014]
PXDN Gene-Disease associations (from GenCC):
  • anterior segment dysgenesis 7
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, PanelApp Australia, ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003169328).
BP6
Variant 2-1638964-C-T is Benign according to our data. Variant chr2-1638964-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00726 (1106/152312) while in subpopulation AFR AF = 0.0244 (1016/41562). AF 95% confidence interval is 0.0232. There are 14 homozygotes in GnomAd4. There are 532 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PXDNNM_012293.3 linkc.4088G>A p.Gly1363Glu missense_variant Exon 21 of 23 ENST00000252804.9 NP_036425.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PXDNENST00000252804.9 linkc.4088G>A p.Gly1363Glu missense_variant Exon 21 of 23 1 NM_012293.3 ENSP00000252804.4 Q92626-1
PXDNENST00000478155.5 linkn.3176G>A non_coding_transcript_exon_variant Exon 13 of 15 2
PXDNENST00000453308.1 linkn.224+338G>A intron_variant Intron 2 of 3 3 ENSP00000414098.1 H7C3W2

Frequencies

GnomAD3 genomes
AF:
0.00723
AC:
1100
AN:
152194
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0244
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00215
AC:
536
AN:
249244
AF XY:
0.00173
show subpopulations
Gnomad AFR exome
AF:
0.0273
Gnomad AMR exome
AF:
0.00180
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000336
Gnomad OTH exome
AF:
0.000990
GnomAD4 exome
AF:
0.00106
AC:
1550
AN:
1461668
Hom.:
15
Cov.:
35
AF XY:
0.000983
AC XY:
715
AN XY:
727124
show subpopulations
African (AFR)
AF:
0.0283
AC:
947
AN:
33474
American (AMR)
AF:
0.00204
AC:
91
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00416
AC:
24
AN:
5768
European-Non Finnish (NFE)
AF:
0.000238
AC:
265
AN:
1111842
Other (OTH)
AF:
0.00345
AC:
208
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
80
161
241
322
402
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00726
AC:
1106
AN:
152312
Hom.:
14
Cov.:
33
AF XY:
0.00714
AC XY:
532
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.0244
AC:
1016
AN:
41562
American (AMR)
AF:
0.00327
AC:
50
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000456
AC:
31
AN:
68034
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
57
114
171
228
285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00299
Hom.:
10
Bravo
AF:
0.00836
ESP6500AA
AF:
0.0225
AC:
96
ESP6500EA
AF:
0.000589
AC:
5
ExAC
AF:
0.00274
AC:
332
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000436
EpiControl
AF:
0.000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 14, 2023
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Anterior segment dysgenesis 7 Benign:1
Oct 28, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
2.4
DANN
Benign
0.19
DEOGEN2
Benign
0.0094
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.12
N
LIST_S2
Benign
0.37
T
MetaRNN
Benign
0.0032
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
0.15
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-0.22
N
REVEL
Benign
0.12
Sift
Benign
0.95
T
Sift4G
Benign
1.0
T
Polyphen
0.018
B
Vest4
0.22
MVP
0.17
MPC
0.53
ClinPred
0.0069
T
GERP RS
3.2
Varity_R
0.038
gMVP
0.23
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61747868; hg19: chr2-1642736; API